Replies to post #71278 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

HappyLibrarian,

I guess Rocky just quit and the story ended. Funny. There is a price to be paid for not giving up. Sure Cognate might find a way to survive but they certainly can not thrive without NWBO. Their NWBO stock is worth the same price ours is and sure they have the equity from their build out but that could start disappearing quickly. They would be so wrapped up in litigation from disgruntled investors that making a 5 mile long spool of tangled monofilament fishing line covered in pine pitch and mouse trap glue good again using only your bare hands would be easier. Then add to that the overhead costs of maintaining their manufacturing facilities while they are busy in court and trying to run a business sullied by default and things wouldn't be much fun at all. They do have a well known big investor who might not be too happy right? Best wishes.

[Poor Man -]

Eventually, the body starves. We by the way are the part of the NWBO body that is getting cannibalize since Cognate does not get diluted.

Since Cognate is not public, we don't know much about the company's financial condition to know how much they depend on NWBO. But Cognate does have to be paid, like any CRO would need to be paid, so I don't know how meaningful it is to bring Cognate into the equation.

But, Cognate is a Toucan Capital portfolio company, so many (if not all) the investors on the fund side for NWBO are the same as for Cognate. So you can make a case that the Cognate investors are also being hurt by the NWBO dilution, similar to all other investors.